These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 3916088

  • 1. Evaluation of valvular heart disease by invasive methods.
    Fontana ME, Lewis RP.
    Cardiovasc Clin; 1985; 15(1):165-85. PubMed ID: 3916088
    [Abstract] [Full Text] [Related]

  • 2. [Which patients with heart valve diseases require invasive evaluation?].
    Ugartemendia C, Esplugas E.
    Rev Esp Cardiol; 1995 Apr; 48(4):215-22. PubMed ID: 7740141
    [No Abstract] [Full Text] [Related]

  • 3. Clinical aspects of acquired valvular heart disease.
    Fowler NO.
    Semin Roentgenol; 1979 Apr; 14(2):83-95. PubMed ID: 462200
    [No Abstract] [Full Text] [Related]

  • 4. Noninvasive graphic evaluation: phonocardiography and echocardiography.
    Salerni R, Shaver JA.
    Cardiovasc Clin; 1986 Apr; 16(2):173-210. PubMed ID: 3742521
    [Abstract] [Full Text] [Related]

  • 5. Non-invasive methods are reliable for quantification of valvular stenoses and regurgitation.
    Burckhardt D, Amann FW, Hoffmann A.
    Z Kardiol; 1986 Apr; 75 Suppl 2():1-12. PubMed ID: 2941925
    [No Abstract] [Full Text] [Related]

  • 6. Optimal use of echocardiography in valvular heart disease evaluation.
    Siegel RJ, Luo H, Makar M, Beigel R.
    Heart; 2015 Jun; 101(12):977-86. PubMed ID: 25801000
    [No Abstract] [Full Text] [Related]

  • 7. Silent valvular heart disease.
    Harvey WP.
    Cardiovasc Clin; 1973 Jun; 5(2):77-95. PubMed ID: 4780194
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Minimal cardial transit times in cardiac diagnostics. Measurements using gamma retina and Indium-113m. II. Minimal cardial transit times in various heart valve diseases].
    Schicha H, Vyska K, Becker V, Seipel L, Feinendegen LE.
    Z Kreislaufforsch; 1971 Nov; 60(11):947-57. PubMed ID: 4946251
    [No Abstract] [Full Text] [Related]

  • 16. Clinical approach and management of acquired valvular heart disease.
    Fuster V, Brandenburg RO, Giuliani ER, McGoon DC.
    Cardiovasc Clin; 1980 Nov; 10(3):125-59. PubMed ID: 6991110
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cardiovascular abnormalities in the athlete: recommendations regarding eligibility for competition. Task force II: Acquired valvular heart disease.
    Cheitlin MD, Bonow RO, Parmley WW, Roberts WC, Swan HJ, Williams JF.
    J Am Coll Cardiol; 1985 Dec; 6(6):1209-14. PubMed ID: 2856840
    [No Abstract] [Full Text] [Related]

  • 19. [Auscultation and phonocardiography in acquired heart defects].
    Michel D.
    Internist (Berl); 1965 Dec; 6(12):515-29. PubMed ID: 5334459
    [No Abstract] [Full Text] [Related]

  • 20. Quantitative angiocardiographic methods in the evaluation of valvular heart disease.
    Dodge HT, Kennedy JW, Petersen JL.
    Prog Cardiovasc Dis; 1973 Dec; 16(1):1-23. PubMed ID: 4268503
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.